Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fibroblast cellular environment, also known as the fibroblast niche or stroma, is a complex biological system comprising fibroblasts, the extracellular matrix (ECM), and a variety of secreted growth factors and cytokines (Source: NIH, StatPearls). Fibroblasts are the primary cells responsible for synthesizing ECM components like collagen and elastin, which provide structural support to tissues and play a vital role in wound healing and tissue repair. In pathological conditions such as idiopathic pulmonary fibrosis or the tumor microenvironment in cancer, fibroblasts become chronically activated into myofibroblasts, leading to excessive ECM deposition and tissue stiffening. While the environment itself is not a single molecular target, specific components within it—such as the TGF-beta receptor, Fibroblast Activation Protein (FAP), and various integrins—are targeted by drugs like Nintedanib and Pirfenidone to treat fibrotic diseases (Source: PubMed, PMID: 28951313). Understanding the dynamics of this environment is crucial for developing therapies that can reverse fibrosis or disrupt the supportive stroma that protects tumor cells from chemotherapy.
Therapeutic strategies targeting the fibroblast cellular environment involve the inhibition of pro-fibrotic signaling pathways, such as TGF-beta and PDGF, or the modulation of extracellular matrix-modifying enzymes like lysyl oxidase-like 2 (LOXL2) to prevent excessive tissue scarring and remodeling (Source: PubMed, PMID: 30635081).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibroblast cellular environment.